LLY Stock Rebounds Amid AI-Driven ALS Research Breakthroughs
November 20, 2024 at 13:18 PM EST
Verge Genomics and Eli Lilly have made significant progress in their collaboration to develop ALS treatments, identifying two promising drug targets using AI technology.
